Cargando…
Secretory Acid Sphingomyelinase in the Serum of Medicated Patients Predicts the Prospective Course of Depression
Major depressive disorder (MDD) is a highly prevalent and devastating psychiatric illness with strong individual and societal burdens. However, biomarkers to improve the limited preventive and therapeutic approaches are scarce. Multilevel evidence suggests that the pathophysiological involvement of...
Autores principales: | Mühle, Christiane, Wagner, Claudia Johanna, Färber, Katharina, Richter-Schmidinger, Tanja, Gulbins, Erich, Lenz, Bernd, Kornhuber, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617165/ https://www.ncbi.nlm.nih.gov/pubmed/31200571 http://dx.doi.org/10.3390/jcm8060846 |
Ejemplares similares
-
Peripheral Acid Sphingomyelinase Activity Is Associated with Biomarkers and Phenotypes of Alcohol Use and Dependence in Patients and Healthy Controls
por: Mühle, Christiane, et al.
Publicado: (2018) -
mRNA Expression of SMPD1 Encoding Acid Sphingomyelinase Decreases upon Antidepressant Treatment
por: Rhein, Cosima, et al.
Publicado: (2021) -
Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity
por: von Zimmermann, Claudia, et al.
Publicado: (2021) -
Physical Activity and Body Composition Are Associated With Severity and Risk of Depression, and Serum Lipids
por: von Zimmermann, Claudia, et al.
Publicado: (2020) -
Characterization of a Neutral Sphingomyelinase Activity in Human Serum and Plasma
por: Mühle, Christiane, et al.
Publicado: (2023)